‘The dual pandemic’ of suicide and COVID-19: A biopsychosocial narrative of risks and prevention
2
Centre for Neuroscience, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), City of Knowledge, Panama City, Republic of Panama.
|
Publication type: Journal Article
Publication date: 2021-01-01
scimago Q1
wos Q1
SJR: 1.606
CiteScore: 8.6
Impact factor: 3.9
ISSN: 01651781, 18727123
PubMed ID:
33229123
Psychiatry and Mental health
Biological Psychiatry
Abstract
• Coronavirus disease 2019 (COVID-19) has emerged as a global health threat. • Number of suicidal deaths during times of COVID-19 is rising though data is limited. • Pandemics lead to several risk factors for suicidality like isolation, loneliness, economic fallout, domestic abuse, stigma and fear. • Biological vulnerabilities (family history of suicide, substance use, etc.) and psychosocial risks (migration, old age, low socio-economic class, etc.) amplify the suicidal risks of pandemics. • Stress and immune reaction to infections like COVID-19 are hypothesized as possible linking pathways to suicidal risk. • Suicide-prevention is discussed as an integral part of public health response to pandemics. The Coronavirus disease 2019 (COVID-19) has emerged as a new global health threat. By increasing the risk of isolation, fear, stigma, abuse and economic fallout, COVID-19 has led to increase in risk of psychiatric disorders, chronic trauma and stress, which eventually increase suicidality and suicidal behavior. There is limited data on association of pandemics and suicides. Cases of suicides have been rising since COVID-19 first emerged in China. The association between suicides and pandemics can possibly be explained through various models like Durkheim's theory, Joiner's interpersonal theory, social stress theory, biological theories, etc. The frontline workers, elderly, migrants, homeless, socio-economically impoverished classes as well as those with pre-existing mental disorders, substance abuse and family history of suicides are at higher risk. Suicides are preventable and need early detection, awareness and socio-culturally tailored interventions. This narrative review draws global perspectives on the association of suicidality and pandemics, the theories and risk factors related to same based on the available evidence. It also hypothesizes neuroimmunity and immune based risk factors as possible links between the psychosocial vulnerabilities and suicide during outbreaks like COVID-19. Proposed strategies of suicide-prevention, as an integral part of public health response to the pandemic are subsequently discussed.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
BMC Psychiatry
6 publications, 3.73%
|
|
|
Psychiatry Research
5 publications, 3.11%
|
|
|
International Journal of Environmental Research and Public Health
4 publications, 2.48%
|
|
|
Frontiers in Public Health
4 publications, 2.48%
|
|
|
Frontiers in Psychiatry
4 publications, 2.48%
|
|
|
Journal of Affective Disorders
4 publications, 2.48%
|
|
|
World Journal of Psychiatry
3 publications, 1.86%
|
|
|
Healthcare
3 publications, 1.86%
|
|
|
Scientific Reports
3 publications, 1.86%
|
|
|
Journal of Psychiatric Research
3 publications, 1.86%
|
|
|
Asian Journal of Psychiatry
3 publications, 1.86%
|
|
|
Sustainable Development Goals Series
3 publications, 1.86%
|
|
|
Journal of Clinical Medicine
2 publications, 1.24%
|
|
|
Humanities and Social Sciences Communications
2 publications, 1.24%
|
|
|
BMC Public Health
2 publications, 1.24%
|
|
|
Translational Psychiatry
2 publications, 1.24%
|
|
|
PLoS ONE
2 publications, 1.24%
|
|
|
Consortium Psychiatricum
2 publications, 1.24%
|
|
|
Journal of Affective Disorders Reports
2 publications, 1.24%
|
|
|
Cureus
2 publications, 1.24%
|
|
|
Mental Health Science
2 publications, 1.24%
|
|
|
Suicide and Life-Threatening Behavior
2 publications, 1.24%
|
|
|
Injury Prevention
2 publications, 1.24%
|
|
|
Journal of Mental Health Training, Education and Practice
1 publication, 0.62%
|
|
|
European Journal of Management and Business Economics
1 publication, 0.62%
|
|
|
JMIR Research Protocols
1 publication, 0.62%
|
|
|
Experimental and Therapeutic Medicine
1 publication, 0.62%
|
|
|
Current Opinion in Psychiatry
1 publication, 0.62%
|
|
|
Psychosomatic Medicine
1 publication, 0.62%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Springer Nature
38 publications, 23.6%
|
|
|
Elsevier
30 publications, 18.63%
|
|
|
MDPI
14 publications, 8.7%
|
|
|
Frontiers Media S.A.
10 publications, 6.21%
|
|
|
Wiley
9 publications, 5.59%
|
|
|
SAGE
8 publications, 4.97%
|
|
|
Taylor & Francis
7 publications, 4.35%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
5 publications, 3.11%
|
|
|
BMJ
4 publications, 2.48%
|
|
|
JMIR Publications
3 publications, 1.86%
|
|
|
Baishideng Publishing Group
3 publications, 1.86%
|
|
|
Emerald
2 publications, 1.24%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.24%
|
|
|
Eco-Vector LLC
2 publications, 1.24%
|
|
|
Medknow
2 publications, 1.24%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.24%
|
|
|
American Psychological Association (APA)
2 publications, 1.24%
|
|
|
Spandidos Publications
1 publication, 0.62%
|
|
|
University of Toronto Press Inc. (UTPress)
1 publication, 0.62%
|
|
|
American Medical Association (AMA)
1 publication, 0.62%
|
|
|
Korean Society of Epidemiology
1 publication, 0.62%
|
|
|
Modestum Ltd
1 publication, 0.62%
|
|
|
Hindawi Limited
1 publication, 0.62%
|
|
|
Oxford University Press
1 publication, 0.62%
|
|
|
IntechOpen
1 publication, 0.62%
|
|
|
American Academy of Pediatrics
1 publication, 0.62%
|
|
|
Centre for Evaluation in Education and Science (CEON/CEES)
1 publication, 0.62%
|
|
|
Guilford Publications
1 publication, 0.62%
|
|
|
South Florida Publishing LLC
1 publication, 0.62%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
161
Total citations:
161
Citations from 2024:
47
(29.19%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Banerjee D., Kosagisharaf J. R., Rao T. S. ‘The dual pandemic’ of suicide and COVID-19: A biopsychosocial narrative of risks and prevention // Psychiatry Research. 2021. Vol. 295. p. 113577.
GOST all authors (up to 50)
Copy
Banerjee D., Kosagisharaf J. R., Rao T. S. ‘The dual pandemic’ of suicide and COVID-19: A biopsychosocial narrative of risks and prevention // Psychiatry Research. 2021. Vol. 295. p. 113577.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.psychres.2020.113577
UR - https://doi.org/10.1016/j.psychres.2020.113577
TI - ‘The dual pandemic’ of suicide and COVID-19: A biopsychosocial narrative of risks and prevention
T2 - Psychiatry Research
AU - Banerjee, Debanjan
AU - Kosagisharaf, Jagannatha Rao
AU - Rao, T.S. Sathyanarayana
PY - 2021
DA - 2021/01/01
PB - Elsevier
SP - 113577
VL - 295
PMID - 33229123
SN - 0165-1781
SN - 1872-7123
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Banerjee,
author = {Debanjan Banerjee and Jagannatha Rao Kosagisharaf and T.S. Sathyanarayana Rao},
title = {‘The dual pandemic’ of suicide and COVID-19: A biopsychosocial narrative of risks and prevention},
journal = {Psychiatry Research},
year = {2021},
volume = {295},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/j.psychres.2020.113577},
pages = {113577},
doi = {10.1016/j.psychres.2020.113577}
}